AstraZeneca's coronavirus vaccine trial can continue in the US after being halted due to a participant having a 'serious adverse reaction' (AZN)Business Insider • 10/23/20
Have $1,000? 2 Fantastic Coronavirus Stocks to Buy and Hold for the Next DecadeThe Motley Fool • 10/23/20
AstraZeneca Announces Winners and Recognizes Unsung Heroes of Oncology in 2020 Cancer Community (C2) AwardsBusiness Wire • 10/22/20
Brazil Healthcare Regulator Says Patient in AstraZeneca Coronavirus Vaccine Trial DiesThe Motley Fool • 10/21/20
AstraZeneca shares slide after Brazilian health authority says volunteer in Covid vaccine study diesCNBC • 10/21/20
AstraZeneca Could Resume US COVID-19 Vaccine Trial This Week As FDA Review Complete: ReportBenzinga • 10/21/20
Exclusive: AstraZeneca U.S. COVID-19 vaccine trial may resume as soon as this week - sourcesReuters • 10/20/20
There are seven coronavirus vaccine candidates being tested in the U.S. — here’s where they standMarket Watch • 10/14/20